Research and Development

Showing 15 posts of 9594 posts found.

Globe faces cancer ‘tidal wave’

February 5, 2014 Research and Development, Sales and Marketing Cancer, WHO, globe, world cancer report

The World Health Organisation has warned of a ‘tidal wave’ of cancer cases which it says will sweep across the …
National Institutes of Health image

Drug giants team up for Alzheimer’s

February 5, 2014 Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
david_lockwood

Laird chief executive takes up key innovation role





February 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david lockwood, laird

David Lockwood OBE has been appointed to an influential business innovation role in the UK as non-executive chair of the …

Three new entries to Cancer Drugs Fund

February 5, 2014 Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …

Pfizer breast cancer drug shows promise

February 4, 2014 Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial.  The pill was administered …
screen_shot_2014-02-04_at_08

Sartorius hires laboratory manager

February 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Melingo, satorius

Lab and technology firm Sartorius has appointed Michael Melingo to be its laboratory manager. Melingo is to succeed Dominique Baly …
J&J image

J&J reveals more on transparency policy

February 3, 2014 Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …
CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …
eddie_williams_novo

Novo Nordisk makes Eddie Williams senior VP

February 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, eddie williams

Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit. Williams brings three …
Aerial view of Milton Park image

UK invests in Oxford bioscience site

January 31, 2014 Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government

The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …
cornelius_merlini_metamark

Metamark names new chief commercial officer

January 31, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cornelius, metamark

US Biotech firm Metamark Genetics has named the former general manager of HealthTronics Laboratory Solutions Cornelius Merlini, as its senior …

Stem cell breakthrough heralded by scientists

January 30, 2014 Research and Development, Sales and Marketing BBC, regenerative medicine, stap, stem cell

Researchers have discovered a simple method of producing mice stem cells that could mark a new era of regenerative medicine.  …
screen_shot_2014-02-04_at_14

Novo Nordisk appoints chief medical officer

January 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, todd hobbs

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America.   In this role …
screen_shot_2014-01-29_at_10

High-dose Copaxone the right medicine for Teva

January 29, 2014 Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …
The Gateway to Local Adoption Series

Latest content